Cubist Systematic Strategies’s Modular Medical MODD Stock Holding History

Cubist Systematic Strategies’s Portfolio MODD Stock Details MODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-418	Closed	-$14.5K	–	3895
2023 Q3	$14.5K	Buy	+418	New	+$13.3K	﹤0.01%	3119

Other funds holding MODD

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's MODD Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Modular Medical (MODD) in Q4 2023, closing a stake of 418 shares — an estimated $14.5K sold.

Cubist Systematic Strategies first reported a position in MODD in Q3 2023 and held it in 1 quarter. The position peaked at $14.5K in Q3 2023. 22 funds tracked by Wall St. Rank hold MODD as of Q4 2023.

Cubist Systematic Strategies reported no remaining Modular Medical position as of Q4 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 418 Modular Medical shares in Q4 2023, an estimated $14.5K.
Cubist Systematic Strategies first reported a position in Modular Medical in Q3 2023 and held it in 1 quarter.
Cubist Systematic Strategies's Modular Medical position peaked at $14.5K in Q3 2023.
22 funds tracked by Wall St. Rank held Modular Medical as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.